CIMFX
Price
$24.70
Change
-$0.13 (-0.52%)
Updated
Dec 17 closing price
RIDEX
Price
$24.73
Change
-$0.13 (-0.52%)
Updated
Dec 17 closing price
Ad is loading...

CIMFX vs RIDEX

Header iconCIMFX vs RIDEX Comparison
Open Charts CIMFX vs RIDEXBanner chart's image
American Funds Income Fund of Amer 529F1
Price$24.70
Change-$0.13 (-0.52%)
VolumeN/A
CapitalizationN/A
American Funds Income Fund of Amer R4
Price$24.73
Change-$0.13 (-0.52%)
VolumeN/A
CapitalizationN/A
CIMFX vs RIDEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIMFX vs. RIDEX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIMFX is a Buy and RIDEX is a Buy.

FUNDAMENTALS
Fundamentals
CIMFX (123B) and RIDEX (123B) have equal amount of cash in the bank . CIMFX (3.66) and RIDEX (3.50) have matching dividends . CIMFX was incepted earlier than RIDEX: CIMFX (22 years) vs RIDEX (22 years). CIMFX (40.00) and RIDEX (40.00) have comparable annual turnover. CIMFX (250) and RIDEX (250) have matching initial minimum investment requirements. CIMFX (10.84) and RIDEX (10.69) have marching annual gain over last year. CIMFX return over 5 years is better than : 27.37 vs. RIDEX (20.11).
CIMFXRIDEXCIMFX / RIDEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years22 years-
Gain YTD9.4669.320102%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets123B123B100%
Annual Yield % from dividends3.663.50104%
Returns for 1 year10.8410.69101%
Returns for 3 years9.216.06152%
Returns for 5 years27.3720.11136%
Returns for 10 years59.7732.36185%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FTFT0.290.02
+7.50%
Future FinTech Group
ERIE424.341.10
+0.26%
Erie Indemnity Company
BY30.75-0.49
-1.57%
Byline Bancorp
CSWI379.74-9.43
-2.42%
CSW Industrials
FATE1.88-0.12
-6.00%
Fate Therapeutics